세계의 임상 검사 서비스 시장 : 어세이 유형별, 장소별, 제품별, 국가별 예측과 전략 및 동향 - 경영진 및 컨설턴트 가이드 포함 - 제8판(2025-2029년)

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

The report provides data that analysts and planners can use. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. The New Demand for Clinical Testing
• 2.2. Defining the Opportunity
  • 2.2.1. Revenue Market Size
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. Segmentation - Different Approaches
  • 3.2.1. Traditional Market Segmentation
  • 3.2.2. Laboratory Focus and Segmentation
• 3.3. Structure of Clinical Testing Industry
  • 3.3.1. The Hospital Lab - Share of the Pie
  • 3.3.2. Key Role for Economies of Scale
  • 3.3.3. Physician Office Lab's are Still Here
  • 3.3.4. Physician's and POCT - Reviving Patient Service in China
• 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

• 4.1. Growth Is Pushed from Many Sides
  • 4.1.1. Demographic Impacts on Consumption
  • 4.1.2. COVID Related Impacts
  • 4.1.3. Point of Care Testing Makes a Difference
  • 4.1.4. Alternative Medicine Effect
  • 4.1.5. Esoterics
  • 4.1.6. A New Laboratory Discipline
• 4.2. Factors at Work to Shrink the Market
  • 4.2.1. Where are Costs Going?
  • 4.2.2. Population Effects
  • 4.2.3. Management Practices
  • 4.2.4. Wellness
  • 4.2.5. Cannabilization
  • 4.2.6. Point of Care
• 4.3. Automation and Laboratory Trends
  • 4.3.1. Traditional Automation and Centralization
  • 4.3.2. The New Automation, Decentralization and Point Of Care
  • 4.3.3. Instruments Key to Market Share
  • 4.3.4. Bioinformatics Plays a Role
  • 4.3.5. PCR Takes Command
  • 4.3.6. Next Generation Sequencing Fuels a Revolution
  • 4.3.7. NGS Impact on Pricing
  • 4.3.8. Whole Genome Sequencing, A Brave New World
  • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.3.10. Shifting Role of Diagnostics

5. Clinical Laboratory Services Recent Developments

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. Source Bioscience Acquires Cambridge Clinical Labs
• 5.3. Labcorp Acquires Select Assets of BioReference Health
• 5.4. hc1 + Accumen Launches Clinical Excellence Solutions
• 5.5. Labcorp enters lab management, services agreement with Inspira Health
• 5.6. Aventa Genomics Receives Favorable Pricing Determination
• 5.7. Perseus Completes Acquisition of Matrix Sistemas e Servicos Ltda
• 5.8. Delve Bio Announces Partnership with Broad Clinical Labs for mNGS
• 5.9. Quest Dx to Acquire Select Lab Assets from Allina Health
• 5.10. Eurofins buys Ascend Clinical LLC
• 5.11. Atalan Sees Potential in Hospital Outreach Business
• 5.12. Challenge Bringing Routine Testing to Point of Care
• 5.13. Natera Cites Test Volume Growth, Rosy Reimbursement
• 5.14. Patients Becoming Stakeholders in Infectious Disease Testing
• 5.15. MedGenome Acquires Prognosis Laboratories
• 5.16. Brooks Automation acquires Aim Lab
• 5.17. Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
• 5.18. Mayo Clinic Laboratories and Helix to provide Biopharma Services
• 5.19. CompuGroup Medical acquires Medicus Laboratory Information Systems
• 5.20. Quest Diagnostics acquires Summa Health outreach lab
• 5.21. Q2 Solutions Launches Self-Collection Safety Lab Panel
• 5.22. Bionano Genomics Announces Launch of Bionano Laboratories
• 5.23. Labcorp to Spin Off Clinical Development Business
• 5.24. Value-Based Care Growing More Profitable for Labs
• 5.25. Lucid Diagnostics Reports Revenue Growth
• 5.26. NGS Cancer Testing Decision Appeases Industry
• 5.27. Clinical Labs Make Strong Showing in 2021
• 5.28. Seegene to Enter Syndromic MDx Space
• 5.29. EKF Diagnostics Acquires Advanced Diagnostic Laboratory
• 5.30. Molecular Health, EDGC Ink Liquid Biopsy Partnership
• 5.31. ProPhase Labs Acquires Nebula Genomics for $14.6M
• 5.32. Karius Cell-Free DNA Method to Detect Infection Validated
• 5.33. EDGC Enters Liquid Biopsy Space With Cf DNA
• 5.34. TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
• 5.35. Enzo Biochem Q2 Revenues Up 62 Percent
• 5.36. Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
• 5.37. FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
• 5.38. Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
• 5.39. Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
• 5.40. Cooperative Aims to Expand Clinical, Commercial NGS Access

6. Profiles of Key Companies

• 6.1. Accel Diagnostics
• 6.2. Acibadem Labmed Laboratory
• 6.3. ACM Medical Laboratory
• 6.4. Adicon Clinical Laboratories
• 6.5. Aegis Science Corporation
• 6.6. American Bio-Clinical Laboratories, Int'l
• 6.7. ARUP Laboratories
• 6.8. Ascend Clinical
• 6.9. Bio-Reference Laboratories
• 6.10. Bioscientia Institut fur Medizinische Diagnostik GmbH
• 6.11. BP Healthcare Group
• 6.12. C2N Diagnostics
• 6.13. Clinical Reference Laboratory
• 6.14. Clongen Laboratories
• 6.15. CompuNet Clinical Laboratories
• 6.16. DASA
• 6.17. DIAN Diagnostics Co., Ltd.
• 6.18. Enzo Biochem
• 6.19. Eone Laboratories
• 6.20. Eurofins Scientific
• 6.21. Exagen Diagnostics
• 6.22. Flow Health
• 6.23. Fyr Diagnostics
• 6.24. Genzyme Corporation
• 6.25. Guangzhou Kingmed Diagnostics Group Co., Ltd.
• 6.26. Haystack Oncology (Quest Dx)
• 6.27. Innoquest Pathology
• 6.28. Integrated Regional Laboratories
• 6.29. KDL Group
• 6.30. Laboratory Corporation of America
• 6.31. Lifelabs (Quest)
• 6.32. Mayo Clinic Laboratories
• 6.33. Medicover
• 6.34. Myriad Genetics
• 6.35. NeoGenomics
• 6.36. OncoDNA
• 6.37. Oncohost
• 6.38. Prometheus Laboratories
• 6.39. ProPhase Labs
• 6.40. Psychemedics Corporation
• 6.41. Quest Diagnostics
• 6.42. SkylineDx
• 6.43. Sonic Healthcare
• 6.44. Sophia Genetics
• 6.45. Spectra Laboratories
• 6.46. Streamline Scientific
• 6.47. Synlab
• 6.48. Sysmex Inostics
• 6.49. Unilabs
• 6.50. Werfen

7. The Global Market for Clinical Laboratory Testing

• 7.1. Global Market Overview by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Global Market by Country
• 7.2. Global Market by Assay Type - Overview
  • 7.2.1. Table - Global Market by Assay Type
  • 7.2.2. Chart - Global Market by Assay Type - Base/Final Year Comparison
  • 7.2.3. Chart - Global Market by Assay Type - Base Year
  • 7.2.4. Chart - Global Market by Assay Type - End Year
  • 7.2.5. Chart - Global Market by Assay Type - Share by Year
  • 7.2.6. Chart - Global Market by Assay Type - Segments Growth
• 7.3. Global Market by Place - Overview
  • 7.3.1. Table - Global Market by Place
  • 7.3.2. Chart - Global Market by Place - Base/Final Year Comparison
  • 7.3.3. Chart - Global Market by Place - Base Year
  • 7.3.4. Chart - Global Market by Place - End Year
  • 7.3.5. Chart - Global Market by Place - Share by Year
  • 7.3.6. Chart - Global Market by Place - Segments Growth
• 7.4. Global Market by Product - Overview
  • 7.4.1. Table - Global Market by Product
  • 7.4.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 7.4.3. Chart - Global Market by Product - Base Year
  • 7.4.4. Chart - Global Market by Product - End Year
  • 7.4.5. Chart - Global Market by Product - Share by Year
  • 7.4.6. Chart - Global Market by Product - Segments Growth

8. Global Clinical Laboratory Diagnostic Markets - By Assay Type

• 8.1. Chemistry
  • 8.1.1. Table Chemistry - by Country
  • 8.1.2. Chart - Chemistry Growth
• 8.2. Microbiology
  • 8.2.1. Table Microbiology - by Country
  • 8.2.2. Chart - Microbiology Growth
• 8.3. Hematology
  • 8.3.1. Table Hematology - by Country
  • 8.3.2. Chart - Hematology Growth
• 8.4. Anatomic Pathology
  • 8.4.1. Table Anatomic Pathology - by Country
  • 8.4.2. Chart - Anatomic Pathology Growth
• 8.5. Molecular Diagnostics
  • 8.5.1. Table Molecular Diagnostics - by Country
  • 8.5.2. Chart - Molecular Diagnostics Growth
• 8.6. Esoteric
  • 8.6.1. Table Esoteric - by Country
  • 8.6.2. Chart - Esoteric Growth

9. Global Clinical Laboratory Diagnostic Markets - By Place

• 9.1. In Patient Hospital
  • 9.1.1. Table In Patient Hospital - by Country
  • 9.1.2. Chart - In Patient Hospital Growth
• 9.2. Out Patient Hospital
  • 9.2.1. Table Out Patient Hospital - by Country
  • 9.2.2. Chart - Out Patient Hospital Growth
• 9.3. Independent Laboratory
  • 9.3.1. Table Independent Laboratory - by Country
  • 9.3.2. Chart - Independent Laboratory Growth
• 9.4. Physicians Office Laboratory
  • 9.4.1. Table Physicians Office Laboratory - by Country
  • 9.4.2. Chart - Physicians Office Laboratory Growth
• 9.5. Other Laboratory
  • 9.5.1. Table Other Laboratory - by Country
  • 9.5.2. Chart - Other Laboratory Growth

10. Global Clinical Laboratory Diagnostic Markets - By Product

• 10.1. Instruments
  • 10.1.1. Table Instruments - by Country
  • 10.1.2. Chart - Instruments Growth
• 10.2. Reagents
  • 10.2.1. Table Reagents - by Country
  • 10.2.2. Chart - Reagents Growth
• 10.3. Labour
  • 10.3.1. Table Labour - by Country
  • 10.3.2. Chart - Labour Growth
• 10.4. Overhead
  • 10.4.1. Table Overhead - by Country
  • 10.4.2. Chart - Overhead Growth
• 10.5. Other Product
  • 10.5.1. Table Other Product - by Country
  • 10.5.2. Chart - Other Product Growth

11. The Future of the Clinical Laboratory

12. Appendices

• 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
• 12.2. The Most Used IVD Assays
• 12.3. The Highest Grossing Assays